SCHEMBL23770684

SCHEMBL23770684

Cc1ccc(C#N)cc1-c1nc(NSc2cccc(N3CCNCC3)n2)ccc1C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2C9 P11712 1/20 0.35
JAK2 O60674 1/20 0.34
JAK3 P52333 1/20 0.34
HTR2C P28335 3/20 0.34
PIM1 P11309 2/20 0.33
CYP2C19 P33261 1/20 0.33
PRKD1 Q15139 1/20 0.33
PRKD2 Q9BZL6 1/20 0.33
DRD2 P14416 1/20 0.33
DRD3 P35462 1/20 0.33
SOS1 Q07889 1/20 0.32
KARS1 Q15046 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
PIM3 Q86V86 1/20 0.32
PIM2 Q9P1W9 1/20 0.32
CHEK1 O14757 2/20 0.32
ERG P11308 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770770 0.89 ADRB2 (0.38) ADRB2CYP1A2CYP2C9HTR2CCYP2C19
SCHEMBL23770663 0.87 CYP1A2 (0.43) ADRB2CYP1A2CYP2C9HTR2CCYP2C19
SCHEMBL23770444 0.83 ADRB2 (0.42) ADRB2CYP1A2CYP2C9HTR2CCYP2C19
SCHEMBL23770652 0.83 HSD11B1 (0.32) ALDH1A1
SCHEMBL19951408 0.82 ADRB2 (0.35) ADRB2CYP1A2CYP2C9JAK2JAK3
SCHEMBL23770453 0.82 CYP1A2 (0.40) ADRB2CYP1A2CYP2C9PIM1CYP2C19
SCHEMBL23770452 0.80 PDE10A (0.34)
SCHEMBL23770466 0.80 CYP1A2 (0.37) CYP1A2CYP2C19DRD2SOS1HTR3E
SCHEMBL23770560 0.79 CYP1A2 (0.45) ADRB2CYP1A2CYP2C9HTR2CPIM1
SCHEMBL23770433 0.79 PDE10A (0.36) CYP1A2CYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed